HomePHAR • NASDAQ
add
Pharming Group N V ADS each representing 10 Ord Shs
Previous close
$16.42
Year range
$7.79 - $21.34
Market cap
1.04B EUR
Avg Volume
22.12K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 106.53M | 14.96% |
Operating expense | 82.37M | 19.85% |
Net income | 5.33M | 86.36% |
Net profit margin | 5.00 | 62.34% |
Earnings per share | 0.01 | 40.00% |
EBITDA | 6.24M | -67.91% |
Effective tax rate | -11.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 179.10M | 6.68% |
Total assets | 499.96M | 25.00% |
Total liabilities | 222.86M | 24.56% |
Total equity | 277.10M | — |
Shares outstanding | 701.68M | — |
Price to book | 42.10 | — |
Return on assets | 1.56% | — |
Return on capital | 1.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 5.33M | 86.36% |
Cash from operations | 10.71M | 14.75% |
Cash from investing | -45.00K | 99.54% |
Cash from financing | 1.04M | 147.10% |
Net change in cash | 12.94M | 326.22% |
Free cash flow | 29.27M | 424.34% |
About
Founded
1988
Website
Employees
407
